Global Patient Support Programs (PSP) Market Report 2023 to 2030

Global Patient Support Programs (PSP) Market Analysis

$ 3999

The Global Patient Support Programs (PSP) Market was valued at $50.7 Bn in 2023 and is predicted to grow at a CAGR of 15.3% from 2023 to 2030, to $137.4 Bn by 2030. It is expected to reach more than 2.5 times the current value within 7 years. Such exponential growth is driven by factors like the aging population, the increasing prevalence of chronic diseases, the rising cost of healthcare, and the development of new technology. Some of the key players in the global patient support program market include Pfizer, Novartis, Roche, and Merck.

ID: IN10GLHS014 CATEGORY: Healthcare Services GEOGRAPHY: Global

Buy Now

Global Patient Support Programs (PSP) Market Executive Summary

The Global Patient Support Programs (PSP) Market was valued at $50.7 Bn in 2023 and is predicted to grow at a CAGR of 15.3% from 2023 to 2030, to $137.4 Bn by 2030.

The Patient Support Program (PSP) market refers to the range of programs and services that are designed to support patients and improve their outcomes. These programs can include a variety of services, such as medication therapy management, disease management, patient education, and financial assistance. The primary aim of PSPs is to enhance patient care, addressing a variety of needs through comprehensive support services. These initiatives manage and support the patient throughout their treatment journey. Also known as the Patient Assistance Program (PAP), these programs provide access to drugs with little or no cost. One of the renowned programs is Pfizer RxPathways which helps eligible patients get access to Pfizer medicines, including offering insurance support, co-pay assistance, and free or discounted medications. Novartis Patient Assistance Foundation, Inc. (NPAF) offers free medications to eligible patients experiencing financial hardship. Some others are Jannsen CarePath, Amgen Safety Net Foundation, and Lily Cares.

High-income countries tend to have higher healthcare expenditures, as people in these countries can afford more expensive healthcare services. For example, the United States has one of the highest levels of healthcare expenditure in the world, with healthcare spending representing approximately 18% of GDP. Many companies operate in the patient support program market, including pharmaceutical companies, healthcare providers, and technology companies. Various factors are driving the market but some factors act as hindrances in growth. Those factors are limited access to healthcare and patients hesitant to participate in PSPs.

Global Patient Support Programs (PSP) Market Report 2023 to 2030

Market Dynamics

Market Growth Drivers

Increasing Geriatric Population: The global population is aging, and this trend is expected to continue in the coming years. In 2022, there were 771 million people aged 65+ years globally, accounting for almost 10% of the world's population. This segment has been growing at an increasing rate, and it's expected to hit 16% in 2050, and eventually 24% by 2100. As people live longer, they are more likely to develop chronic conditions that require ongoing management and support. This is driving the demand for patient support programs that can help improve patient outcomes and reduce the burden of chronic diseases. The prevalence of chronic diseases, such as diabetes, cardiovascular disease, and cancer, is increasing globally. These conditions often require ongoing management and support, which is driving the demand for patient support programs.

Development of New Technologies: The development of new technologies, such as wearable devices and telemedicine, is enabling more personalized and effective patient support programs. Technologies like Telehealth, AI and machine learning, blockchain tech, patient portals, genomic medicines, AR/VR, pharmacogenomics, remote patient monitoring, and digital therapeutics enhance patient engagement, adherence to treatment plans, and overall health outcomes, thereby increasing the demand for comprehensive support programs and expanding the market.

Rising Cost of Healthcare: An alarming 30 percent to 61 percent of patients do not adhere to their treatment regimen – leading to the loss of efficacy for disease management. The cost of healthcare is increasing globally, and this trend is expected to continue in the coming years. Patient support programs can help to reduce the overall cost of healthcare by improving patient outcomes and reducing the need for hospitalization and other costly interventions. The expansion of healthcare coverage and the increasing availability of telemedicine are making it easier for patients to access healthcare services. This is contributing to the growth of the patient support program market.

Market Restraints

Limited Access to Healthcare: In some parts of the world, access to healthcare is limited, and many patients may be unaware of the benefits of patient support programs or may not know how to access these programs, patient support programs require resources, such as trained staff and funding, to be effective. Almost a quarter of the global population, 23 percent, lived below the US$3.65 poverty line, and almost half, 47 percent, lived below the US$6.85 poverty line, as reported in the 2022 Poverty and Shared Prosperity report. With such limited resources, it is nearly impossible for them to access healthcare. That restricts the growth.

Patients Hesitant to Participate in PSPs: Some patients may be hesitant to participate in patient support programs due to concerns about the confidentiality and privacy of their personal and medical information. Around 20-30% of people leave the treatments from PSPs. Furthermore, there may be regulatory challenges that limit the development and implementation of patient support programs in certain countries.

Regulatory Landscape and Reimbursement Scenario

In the United States, patient support programs are regulated by the Food and Drug Administration (FDA) and are subject to the same regulations as other healthcare products and services. For example, patient support programs that involve the distribution of prescription medications must comply with the FDA's good manufacturing practices regulations and other relevant rules.

In the European Union, patient support programs are regulated by the European Medicines Agency (EMA) and are subject to the same regulations as other healthcare products and services. In general, patient support programs are intended to improve patient outcomes and reduce the burden of chronic diseases. As such, they are typically subject to regulations that are designed to ensure that they are safe and effective.

Competitive Landscape

Here are some of the major key players in the Global Patient Support Programs (PSPs) Market

Allscripts Healthcare, LLC
Orion Health
Cerner Corporation
McKesson Corporation
Athenahealth, Inc.
IBM
Medecision
GetWellNetwork, Inc.
MEDHOST
Lincor
IQVIA
Wolters Kluwer N.V.
Force Therapeutics LLC
Quil
Greenway Health, LLC
Mytonomy
Klara Technologies, Inc.
Solutionreach, Inc.
CureMD Healthcare
Patient Point LLC
Vivify Health
Nuance Communications, Inc.

1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Global Patient Support Programs (PSP) Market Segmentation

By Delivery

In-Person
Telehealth
Printed Materials
Employer or Insurance-based Programs
Community-based Programs
Others

By Therapeutic Area

Health and Wellness
Chronic Disease Management
Others

By Application

Population Health Management
Outpatient Health Management
In-Patient Health Management
Others

By End-user

Payer
Provider
Others

Insights10 will provide you with the reports within 10 key parameters which are:

Market Overview
Market Growth Drivers & Restraints
Epidemiology of Disease Type
Market Segmentation
Market Share
Competitive Landscape
Key Company Profiles
Healthcare Policies & Regulatory Framework
Reimbursement Scenario
Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

Establishing market drivers and trends
Analyzing the regulatory landscape to understand future growth
Market Segment based analysis to obtain revenue/volume
Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to oﬀer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.